Abstract
We conducted a retrospective observational study using remote wearable and mobile application data to identify US public holidays associated with significant changes in sleep behaviors, including sleep duration, bedtime and waketime, and the consistency of sleep timing, as well as changes in the point prevalence of alcohol use. These metrics were collected and analyzed from objective, high resolution sleep-wake data and survey responses of 24,250 US subscribers to the wrist-worn biometric device platform, WHOOP (Boston, Massachusetts, USA), who were active users during May 1, 2020 through May 1, 2021. Compared to baseline, statistically significant differences in sleep and alcohol measures were found on the US public holidays and their eves. For example, New Year’s Eve corresponded with a sleep consistency decrease of 13.8% (± 0.3), a sleep onset of 88.9 minutes (± 3.2) later, a sleep offset of 78.1 minutes (± 3.1), and more than twice as many participants reported alcohol consumption (138.0% ± 6.7) compared to baseline. The majority of US public holidays and holiday eves were associated with sample-level increases in sleep duration, decreases in sleep consistency, later sleep onset and offset, and increases in the prevalence of alcohol consumption.
Significance Statement US public holidays were associated with increased sleep duration, decreased sleep consistency, and later sleep timing among US adult users of an objective, validated commercial fitness tracker. Holidays were also associated with an increased prevalence of participants having reported alcohol use. Given the adverse health impacts of sleep timing variability on both weekends and during the transition to daylight savings time, and of increased alcohol use on weekends and public holidays, further investigation of the health impacts of these behavioral changes is warranted.
Competing Interest Statement
Two of the authors (EC, RMH) are affiliated to the commercial company WHOOP Inc, however this does not alter the authors' adherence to BMJ policies on sharing data and materials. MEC received consultant payments from Vanda Pharmaceuticals and institutional grants paid to Monash University from the CDC Foundation, with funding provided by BNY Mellon, and from WHOOP, Inc, as well as an institutional gift to Monash University from Hopelab, Inc. MDW received consultant payments from the National Sleep Foundation and the University of Pittsburgh. CAC reports grants/contracts to BWH from Dayzz Live Well, Delta Airlines, Jazz Pharma, Puget Sound Pilots, Regeneron Pharmaceuticals/Sanofi; is/was paid consultant/speaker for Institute of Digital Media and Child Development, Klarman Family Foundation, National Council for Mental Wellbeing, National Sleep Foundation, Physician's Seal, SRS Foundation, Tencent, Teva Pharma Australia, With Deep, & Vanda Pharmaceuticals, in which CAC holds an equity interest; received travel support from Aspen Brain Institute, Bloomage International, Dr. Stanley Ho Medical Development Foundation, German National Academy of Sciences, National Safety Council, National Sleep Foundation, Stanford Medical School, and Vanda; receives research/education gifts through BWH from Arbor Pharmaceuticals, Avadel Pharmaceuticals, Bryte, Alexandra Drane, DR Capital Ltd, Eisai, Harmony Biosciences, Jazz Pharmaceuticals, Johnson & Johnson, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, NeuroCare, Inc., Optum, Philips Respironics, Regeneron, Regional Home Care, ResMed, San Francisco Bar Pilots, Sanofi, Schneider, Simmons, Sleep Cycle. Sleep Number, Sysco, Teva Pharmaceuticals, Vanda; is/was an expert witness in legal cases, including those involving Advanced Power Technologies, Aegis Chemical Solutions, Amtrak; Casper Sleep Inc, C&J Energy Services, Catapult Energy Services Group, Covenant Testing Technologies, Dallas Police Association, Enterprise Rent-A-Car, Espinal Trucking/Eagle Transport Group/Steel Warehouse Inc, FedEx, Greyhound, PAR Electrical Contractors, Product & Logistics Services LLC/Schlumberger Technology, Puckett EMS, Puget Sound Pilots, Union Pacific Railroad, UPS, and Vanda; royalties from Philips Respironics for the Actiwatch-2 and Actiwatch Spectrum devices. CAC's interests were reviewed and are managed by the BWH and MGB in accordance with their conflict of interest policies. SMWR reports institutional grants paid to Monash University from the CDC Foundation, with funding provided by BNY Mellon, and from WHOOP, Inc.; research grants and consultancy fees from the Cooperative Research Centre for Alertness, Safety and Productivity; and institutional consulting fees paid to Monash University from Teva Pharma Australia, Teva Pharma Ukraine, Vanda Pharmaceuticals, Circadian Therapeutics, BHP Billiton, and Herbert Smith Freehills.
Funding Statement
The authors received no specific funding for this work; however, EC and RMH are affiliated to the commercial company WHOOP, Inc which provided support in the form of salaries but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEC was supported in part by a 2020 to 2021 Australian-American Fulbright Scholarship, with funding from The Kinghorn Foundation. CAC was supported in part by National Institute for Occupational Safety and Health Grant R01OH011773, National Institute on Aging Grant P01AG009975, and National Heart, Lung, and Blood Institute Grants 1R01HL148704 and R56HL151637, and by an endowed professorship given to Harvard in 2004 by Cephalon, Inc.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Monash University Human Research Ethics Committee reviewed and approved the study protocol. All participants in the study consented at registration with WHOOP to the use of their data for the purposes of scientific research and could withdraw consent at any time.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* co-senior authors
Competing Interest Statement: Two of the authors (EC, RMH) are affiliated to the commercial company WHOOP Inc, however this does not alter the authors’ adherence to BMJ policies on sharing data and materials. MÉC received consultant payments from Vanda Pharmaceuticals and institutional grants paid to Monash University from the CDC Foundation, with funding provided by BNY Mellon, and from WHOOP, Inc, as well as an institutional gift to Monash University from Hopelab, Inc. MDW received consultant payments from the National Sleep Foundation and the University of Pittsburgh. CAC reports grants/contracts to BWH from Dayzz Live Well, Delta Airlines, Jazz Pharma, Puget Sound Pilots, Regeneron Pharmaceuticals/Sanofi; is/was paid consultant/speaker for Institute of Digital Media and Child Development, Klarman Family Foundation, National Council for Mental Wellbeing, National Sleep Foundation, Physician’s Seal, SRS Foundation, Tencent, Teva Pharma Australia, With Deep, & Vanda Pharmaceuticals, in which CAC holds an equity interest; received travel support from Aspen Brain Institute, Bloomage International, Dr. Stanley Ho Medical Development Foundation, German National Academy of Sciences, National Safety Council, National Sleep Foundation, Stanford Medical School, and Vanda; receives research/education gifts through BWH from Arbor Pharmaceuticals, Avadel Pharmaceuticals, Bryte, Alexandra Drane, DR Capital Ltd, Eisai, Harmony Biosciences, Jazz Pharmaceuticals, Johnson & Johnson, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, NeuroCare, Inc., Optum, Philips Respironics, Regeneron, Regional Home Care, ResMed, San Francisco Bar Pilots, Sanofi, Schneider, Simmons, Sleep Cycle. Sleep Number, Sysco, Teva Pharmaceuticals, Vanda; is/was an expert witness in legal cases, including those involving Advanced Power Technologies, Aegis Chemical Solutions, Amtrak; Casper Sleep Inc, C&J Energy Services, Catapult Energy Services Group, Covenant Testing Technologies, Dallas Police Association, Enterprise Rent-A-Car, Espinal Trucking/Eagle Transport Group/Steel Warehouse Inc, FedEx, Greyhound, PAR Electrical Contractors, Product & Logistics Services LLC/Schlumberger Technology, Puckett EMS, Puget Sound Pilots, Union Pacific Railroad, UPS, and Vanda; royalties from Philips Respironics for the Actiwatch-2 and Actiwatch Spectrum devices. CAC’s interests were reviewed and are managed by the BWH and MGB in accordance with their conflict of interest policies. SMWR reports institutional grants paid to Monash University from the CDC Foundation, with funding provided by BNY Mellon, and from WHOOP, Inc.; research grants and consultancy fees from the Cooperative Research Centre for Alertness, Safety and Productivity; and institutional consulting fees paid to Monash University from Teva Pharma Australia, Teva Pharma Ukraine, Vanda Pharmaceuticals, Circadian Therapeutics, BHP Billiton, and Herbert Smith Freehills.
Data Availability
Public data sharing for these purposes is ethically and legally restricted. The data is collected and used with the consent of individuals who purchase a WHOOP membership (collectively, "WHOOP Members") and agree to the WHOOP terms of use (https://www.whoop.com/termsofuse/) and privacy policy (https://www.whoop.com/privacy/full-privacy-policy/). While WHOOP terms of use and privacy policy permit WHOOP to use collected data that has been aggregated or de-identified in a manner that no longer identifies an individual for informational purposes, analytics or WHOOP's own research purposes, the consent obtained from WHOOP Members does not extend to making the data publicly available for a third party to use for its own purposes. As such, WHOOP's legal department will not permit the data to be shared for these purposes.
